Traditional MIPS vs MVP reporting options

Traditional MIPS remains the broad reporting framework under the Quality Payment Program. For 2026, performance is evaluated across 4 categories:

• Quality: 30%
• Improvement Activities: 15%
• Promoting Interoperability: 25%
• Cost: 30%

For the Quality category, practices generally report 6 quality measures, including 1 outcome measure or high-priority measure, or a complete specialty measure set. Quality data is collected for the full 12-month performance period from January 1, 2026 through December 31, 2026, and each reported measure must meet the 75% data completeness requirement.

Traditional MIPS may be a better fit when a practice needs broader measure selection flexibility, has multiple specialties under one TIN, or has existing documentation workflows that align better with traditional MIPS quality measures than with a specific MVP.

MIPS Value Pathways, or MVPs, are a more focused reporting option built around specific clinical topics, conditions, or specialties. For 2026, MVPs still use the same core MIPS performance categories and category weights:

• Quality: 30%
• Improvement Activities: 15%
• Promoting Interoperability: 25%
• Cost: 30%

For the Quality category, MVP participants generally select 4 quality measures from the MVP they register for, including 1 outcome measure or high-priority measure. Quality data is collected for the full 12-month performance period from January 1, 2026 through December 31, 2026, and each reported measure must meet the 75% data completeness requirement.

MVPs may reduce measure-selection complexity, but they are only useful when the selected MVP aligns with the practice's specialty, patient population, available data, EHR workflows, and documentation patterns.

The main difference is not simply the number of measures. The practical difference is how reporting is structured. Traditional MIPS lets practices choose from a broader measure inventory, which can be useful when a practice has varied specialties or needs more flexibility. MVPs narrow the reporting framework to a defined pathway, which can make planning cleaner when the MVP matches the practice's specialty and documentation workflows.

• Traditional MIPS offers broader quality measure selection
• MVPs use a focused set of measures tied to a specific pathway
• Both options use the same general category weights in 2026
• Both require quality data for the full 2026 performance year
• Both require 75% data completeness for reported quality measures
• Both require Promoting Interoperability planning unless the category is reweighted or an exception applies
• Cost is generally calculated from administrative claims when applicable
• MVPs require registration, while Traditional MIPS does not require MVP registration

For the 2026 performance year, practices that want to report an MVP must register during the 2026 MVP registration window, which runs from April 1 through November 30, 2026. Registration should be handled early enough to allow time for measure mapping, EHR workflow review, documentation review, and submission preparation.

Beginning in 2026, multispecialty groups that are not small practices and intend to report MVPs are required to report as subgroups or individuals. This makes reporting structure especially important for larger or mixed-specialty practices. A practice should confirm whether the group, subgroup, individual, or APM Entity pathway applies before finalizing its reporting plan.

The best reporting path depends on fit, not just simplicity. A practice should compare Traditional MIPS and MVP options using the actual 2026 requirements, available measures, denominator volume, EHR data availability, documentation workflows, and reporting level.

• Confirm 2026 MIPS eligibility before comparing reporting options
• Review whether an applicable MVP exists for the practice's specialty or clinical focus
• Compare available MVP measures against the practice's actual patient population
• Compare Traditional MIPS measures against existing documentation workflows
• Confirm whether at least one outcome or high-priority measure is practical to report
• Review whether each selected quality measure can meet the 75% data completeness requirement
• Confirm Promoting Interoperability readiness for a minimum 180 continuous day period, unless reweighted or excepted
• Review cost category exposure and which cost measures may apply
• Confirm whether the practice will report individually, as a group, as a subgroup, or through an APM Entity
• Confirm the submission method and reporting pathway before data collection is too far underway

The reporting option affects how data is collected, how measures are mapped, how documentation is reviewed, how dashboards are structured, and how submission preparation is organized. If a practice waits too long to choose between Traditional MIPS and MVP reporting, it may collect data in a way that does not match the selected pathway.

For 2026, practices should make the reporting pathway decision early enough to validate measure denominators, confirm EHR reporting capability, organize supporting documentation, monitor performance throughout the year, and prepare for submission through the selected pathway.